Physical characteristics and aerosol performance of naringin dry powders for pulmonary delivery prepared by spray-drying

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 72, Issue 1, 2009, Pages 206-213

  Sansone, F ^a   Aquino, R P ^a   Gaudio, P Del ^a   Colombo, P ^b   Russo, P ^a  

^a UNIVERSITY OF SALERNO   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

Dry powder inhaler; Excipient free powders; Naringin; Oxidative stress; Spray drying

Indexed keywords

ALCOHOL; AURANTIIN; FLAVONOID;

AEROSOL; ARTICLE; CAPSULE FILLING; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; DRUG SOLUTION; DRY POWDER; INHALER; OXIDATIVE STRESS; PARTICLE SIZE; PHYSICAL CHEMISTRY; SPRAY DRYING; SUSPENSION;

AEROSOLS; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; EXCIPIENTS; FLAVANONES; FREE RADICAL SCAVENGERS; HYDROGEN-ION CONCENTRATION; LUNG; MICROSCOPY, ELECTRON, SCANNING; OXIDATIVE STRESS; PARTICLE SIZE; POWDERS; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL;

EID: 62949241990     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2008.10.007     Document Type: Article

References (32)

1. Rahman I., Biswas S.K., and Kode A. Oxidant and antioxidant balance in the airways and airway diseases. Eur. J. Pharmacol. 533 (2006) 222-239
2. Dworski R. Oxidant stress in asthma. Thorax 55 Suppl 2 (2000) S51-53
3. Calhoun W.J., Reed H.E., Moest D.R., and Stevens C.A. Enhanced superoxide production by alveolar macrophages and air-space cells airway inflammation, and alveolar macrophage density changes after segmental antigen bronchoprovocation in allergic subjects. Am. Rev. Respir. Dis. 145 (1992) 317-325
4. Kanazawa H., Kurihara N., Hirata K., and Takeda T. The role of free radicals in airway obstruction in asthmatic patients. Chest 100 (1991) 1319-1322
5. Vachier I., Damon M., Le Doucen C., de Paulet A.C., Chanez P., Michel F.B., and Godard P. Increased oxygen species generation in blood monocytes of asthmatic patients. Am. Rev. Respir. Dis. 146 (1992) 1161-1166
6. Montuschi P., Kharitonov S.A., and Barnes P.J. Exhaled carbon monoxide and nitric oxide in COPD. Chest 120 (2001) 496-501
7. Rysz J., Stolarek R.A., Luczynski R., Sarniak A., Wlodarczyk A., Kasielski M., and Nowak D. Increased hydrogen peroxide concentration in the exhaled breath condensate of stable COPD patients after nebulized N-acetylcysteine. Pulm. Pharmacol. Ther. 20 (2007) 281-289
8. Brindicci C., Ito K., Resta O., Pride N.B., Barnes P.J., and Kharitonov S.A. Exhaled nitric oxide from lung periphery is increased in COPD. Eur. Respir. J. 26 (2005) 52-59
9. Rahman I. The role of oxidative stress in the pathogenesis of COPD: implications for therapy. Treat. Respir. Med. 4 (2005) 175-200
10. Rosias P.P., Den Hartog G.J., Robroeks C.M., Bast A., Donckerwolcke R.A., Heynens J.W., Suykerbuyk J., Hendriks H.J., Jobsis Q., and Dompeling E. Free radicals in exhaled breath condensate in cystic fibrosis and healthy subjects. Free Radic. Res. 40 (2006) 901-909
11. Hulsmann A.R., Raatgeep H.R., den Hollander J.C., Stijnen T., Saxena P.R., Kerrebijn K.F., and de Jongste J.C. Oxidative epithelial damage produces hyperresponsiveness of human peripheral airways. Am. J. Respir. Crit. Care Med. 149 (1994) 519-525
12. Turner S. Exhaled nitric oxide in the diagnosis and management of asthma. Curr. Opin. Allergy Clin. Immunol. 8 (2008) 70-76
13. Horvath I., Hunt J., Barnes P.J., Alving K., Antczak A., Baraldi E., Becher G., van Beurden W.J., Corradi M., Dekhuijzen R., Dweik R.A., Dwyer T., Effros R., Erzurum S., Gaston B., Gessner C., Greening A., Ho L.P., Hohlfeld J., Jobsis Q., Laskowski D., Loukides S., Marlin D., Montuschi P., Olin A.C., Redington A.E., Reinhold P., van Rensen E.L., Rubinstein I., Silkoff P., Toren K., Vass G., Vogelberg C., and Wirtz H. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur. Respir. J. 26 (2005) 523-548
14. Robroeks C.M., van de Kant K.D., Jobsis Q., Hendriks H.J., van Gent R., Wouters E.F., Damoiseaux J.G., Bast A., Wodzig W.K., and Dompeling E. Exhaled nitric oxide and biomarkers in exhaled breath condensate indicate the presence, severity and control of childhood asthma. Clin. Exp. Allergy 37 (2007) 1303-1311
15. Kumar P., Khanna M., Srivastava V., Tyagi Y.K., Raj H.G., and Ravi K. Effect of quercetin supplementation on lung antioxidants after experimental influenza virus infection. Exp. Lung Res. 31 (2005) 449-459
16. Kumar P., Sharma S., Khanna M., and Raj H.G. Effect of Quercetin on lipid peroxidation and changes in lung morphology in experimental influenza virus infection. Int. J. Exp. Pathol. 84 (2003) 127-133
17. Hu M. Commentary: bioavailability of flavonoids and polyphenols: call to arms. Mol. Pharm. 4 (2007) 803-806
18. Lauro M.R., Torre M.L., Maggi L., De Simone F., Conte U., and Aquino R.P. Fast- and slow-release tablets for oral administration of flavonoids: rutin and quercetin. Drug Dev Ind. Pharm. 28 (2002) 371-379
19. Lauro M.R., Torre M.L., De Simone F., Conte U., and Aquino R.P. Tablet formulation for the fast and sustained-release of flavonoids: naringin and naringenin. S.T.P. Pharma Sci. 11 (2001) 265-269
20. Lauro M.R., De Simone F., Sansone F., Iannelli P., and Aquino R.P. Preparations and release characteristics of Naringin and Naringenin gastro-resistant microparticles by spray-drying. J. Drug Del. Sci. Tech. 17 (2007) 119-124
21. Lauro M.R., Maggi L., Conte U., De Simone F., and Aquino R.P. Rutin and Quercetin gastro-resistant microparticles obtained by spray-drying technique. J. Drug Del. Sci. Tech. 15 (2005) 363-369
22. Telko M.J., and Hickey A.J. Dry powder inhaler formulation. Respir. Care 50 (2005) 1209-1227
23. Lambev I., Krushkov I., Zheliazkov D., and Nikolov N. Antiexudative effect of naringin in experimental pulmonary edema and peritonitis. Eksp. Med. Morfol. 19 (1980) 207-212
24. Manthey J.A., Grohmann K., and Guthrie N. Biological properties of citrus flavonoids pertaining to cancer and inflammation. Curr. Med. Chem. 8 (2001) 135-153
25. Gilani K., Najafabadi A.R., Barghi M., and Rafiee-Tehrani M. The effect of water to ethanol feed ratio on physical properties and aerosolization behavior of spray dried cromolyn sodium particles. J. Pharm. Sci. 94 (2005) 1048-1059
26. Li H.Y., Seville P.C., Williamson I.J., and Birchall J.C. The use of amino acids to enhance the aerosolisation of spray-dried powders for pulmonary gene therapy. J. Gene Med. 7 (2005) 343-353
27. Kanaze F., Kokkalou E., Niopas I., Georgarakis M., Stergiou A., and Bikiaris D. Thermal analysis study of flavonoid solid dispersions having enhanced solubility. J. Thermal Anal. Calorimetry 83 (2006) 283-290
28. Fiegel J., Fu J., and Hanes J. Poly(ether-anhydride) dry powder aerosols for sustained drug delivery in the lungs. J. Control. Release 96 (2004) 411-423
29. Rabbani N.R., and Seville P.C. The influence of formulation components on the aerosolisation properties of spray-dried powders. J. Control. Release 110 (2005) 130-140
30. Mitchell J.P., and Nagel M.W. Particle size analysis of aerosols from medicinal inhalers. Kona 22 (2004) 32-65
31. Hancock B.C., and Parks M. What is the true solubility advantage for amorphous pharmaceuticals?. Pharm. Res. 17 (2000) 397-404
32. Frijlink H.W., and De Boer A.H. Dry powder inhalers for pulmonary drug delivery. Expert Opin. Drug Deliv. 1 (2004) 67-86